NCT03883724

Brief Summary

Nocturia is prevalent in older adults and it vastly reduces quality of life. Yet its treatment remains inadequate because its causes are not well understood, especially nocturnal polyuria or increased urine production at night. This study, which builds on the investigators' ongoing research, would be the first of its kind to explore the role of sleep in nighttime urine production. The findings will contribute important knowledge to guide development of better targeted and more effective therapy for this prevalent and morbid condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 12, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 21, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 22, 2022

Completed
Last Updated

December 22, 2022

Status Verified

November 1, 2022

Enrollment Period

2.8 years

First QC Date

March 12, 2019

Results QC Date

November 25, 2022

Last Update Submit

November 25, 2022

Conditions

Keywords

NocturiaPoor sleep

Outcome Measures

Primary Outcomes (1)

  • Change in Nocturnal Polyuria Index

    Nocturnal Polyuria Index (NPI) is the percentage of 24-hour urine production excreted at night. It is measured using 3-day bladder diary that participants will complete pre- and post-intervention in which the participants document the time and volume of each void during the day and night for 3 days. NPI is calculated using a) nocturnal urine volume (determined by adding the volume of all voids between the times marked in the bladder diary as going to bed with the intent of sleeping and the first awakening to void. The first void after waking is included in the nighttime urine volume), and b) 24-hour urine volume. NPI is calculated as: nocturnal urine volume /24-hour urine volume

    change from baseline nocturnal polyuria index at 4 weeks

Secondary Outcomes (2)

  • Change in Nocturia

    change from baseline nocturia episodes each night at 4 weeks

  • Change in Duration of Uninterrupted Sleep

    Change from baseline duration of uninterrupted sleep at 4 weeks

Study Arms (2)

Brief behavioral treatment for insomnia

EXPERIMENTAL

This group will undergo behavioral intervention proven to improve sleep among older adults: brief behavioral treatment for insomnia

Behavioral: Brief behavioral treatment of insomnia (BBTI)

Information-only control

OTHER

This group is called information-only control. They will be provided sleep-related information. They will also view a video content of which overlap substantially with BBTI but without individualized behavioral instructions.

Behavioral: Information-only control (IC)

Interventions

The BBTI consists of a 45- to 60-minute individual intervention session followed by a 30-minute follow-up session 2 weeks later and 20-minute telephone calls after 1 and 3 weeks. The brief behavioral treatment component will focus on four behaviors that promote sleep through homeostatic, circadian, or association mechanisms. 50 These four interventions are simple to conceptualize and implement, and constitute the core of efficacious multi-modal behavioral treatments for insomnia.

Brief behavioral treatment for insomnia

The IC condition is intended to emulate the behavioral treatment information generally to available patients. It includes instructions to review hand out on healthy sleep practices. We will also use patient education videos on insomnia developed locally and widely used in clinical research. The content of these videos overlap substantially with BBTI but without individualized behavioral instructions. Two weeks later, IC participants will receive a 10-minute follow-up telephone call to encourage continued participation. Participants will be referred to the brochures for specific sleep-related questions.

Information-only control

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • ambulatory and functionally-independent community-dwelling men and women
  • aged 65 years, or more
  • with nocturia ≥2/night
  • poor sleep because of frequent awakenings

You may not qualify if:

  • Unstable or acute medical or central nervous system conditions
  • Untreated, current, severe psychiatric condition
  • Untreated, current, severe overactive bladder syndrome
  • Post void residual \> 30ml
  • Sleep apnea with AHI≥15
  • Currently diagnosed and/or treated Obstructive Sleep Apnea, Restless Legs Syndrome, parasomnia
  • Congestive heart failure, by exam or Beta natriuretic peptide (BNP)\> 30 pmol/L
  • Chronic kidney disease, stage III-V (eGFR\<50)
  • \>14 alcohol drinks per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Sleep DeprivationNocturiaNocturnal Enuresis

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersLower Urinary Tract SymptomsUrological ManifestationsEnuresisUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination Disorders

Results Point of Contact

Title
Shachi Tyagi
Organization
UPittsburgh

Study Officials

  • Shachi Tyagi, MD, MS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 12, 2019

First Posted

March 21, 2019

Study Start

February 1, 2019

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

December 22, 2022

Results First Posted

December 22, 2022

Record last verified: 2022-11

Locations